Replies to post #34887 on Intellipharmaceutics International Inc. (IPCI)

[bluelucky]

It provides options. Currently we have none.

No revenue from mnk. Why leave it there.

Hate to be negative but that seems to be the m.o. of the company - hope things change.

At least this way they wrestle some control back.

How can they even think of generating revenue on it when it is stuck

[bluelucky]

Seems like one to two things is transpiring with mnk

It either does not care about sales and is devoting little if any resources, or

It bought the license to bury it to drive the drive the price down for a cheap takeover.

Think first is most likely (as it has said as much) but who knows